Ethos Pet Brands sharpens post-merger strategy under Greg Shearson
Bottom line
Version 1
Ethos Pet Brands is using Greg Shearson’s public comments to reinforce the company’s post-merger strategy: build scale after the 2023 combination of Natural Balance and Canidae, while leaning into premium nutrition, innovation, and brand differentiation. Ethos was formally unveiled in August 2023 as the new parent company for the two pet food brands, backed by growth capital from Canidae investor L Catterton and Natural Balance investor Nexus Capital Management. The combined company said at launch that both brands would continue serving pet specialty, independent, and ecommerce channels, with manufacturing centered at Canidae’s Brownwood, Texas, facility. More recently, Ethos has continued to position itself around “science-backed nutrition,” transparency, safety testing, and product innovation, including a large slate of new and refreshed products shown at Global Pet Expo 2025. (prnewswire.com)
Why it matters: For veterinary professionals, the interview is less about a single operational change and more about where a mid-sized pet nutrition platform thinks the category is headed. Shearson’s emphasis on premiumization, innovation, and portfolio synergy lines up with Ethos’ broader messaging on limited-ingredient diets, functional formulations, sustainability, and transparency, all themes that increasingly shape conversations with pet parents in clinic. As more consolidated pet food companies sharpen their health-positioning and direct support services, veterinary teams may see more questions about ingredient sourcing, safety programs, specialized nutrition, and how these products compare with more established veterinary-recommended diets. (prnewswire.com)
What to watch: Watch for whether Ethos turns its merger-and-innovation story into broader veterinary channel engagement, new therapeutic or condition-specific nutrition plays, or further executive and product expansion over the next 12 months. (petfoodprocessing.net)
Version 2
Greg Shearson’s “Five Questions” interview with Pet Age offers a window into how Ethos Pet Brands wants the market to view itself nearly three years after the merger of Canidae and Natural Balance: bigger, more focused, and better positioned to compete in premium pet nutrition. While the interview format is executive profile more than breaking news, it underscores a strategy Ethos has been signaling since 2023, pairing scale from consolidation with continued investment in innovation, premium formulations, and brand-specific identities. (prnewswire.com)
That strategy began taking shape publicly in March 2023, when Natural Balance and Canidae announced plans to merge, and became formal in August 2023 when Ethos Pet Brands was unveiled as the new parent company. At the time, the company said the two brands offered complementary portfolios and would continue to serve pet specialty, independent, and ecommerce channels. Ethos also said the Brownwood, Texas, manufacturing facility associated with Canidae would produce products for both brands, a sign that operational integration was part of the value-creation thesis from the start. Financial backing came from L Catterton, the majority shareholder of Canidae, and Nexus Capital Management, the majority shareholder of Natural Balance, which both contributed new growth capital to support integration and long-term expansion. (prnewswire.com)
Shearson’s comments in and around the merger have consistently framed the combination as a scale play in a crowded but still attractive premium segment. In the 2023 launch announcement, he said the leadership team was built to guide the company into its next phase. Trade coverage at the time also described the deal as bringing together two mid-sized brands with room to grow through manufacturing, cost, and portfolio synergies. That framing matters because it helps explain why Ethos has continued to spotlight both operational capability and consumer-facing differentiation rather than folding the brands into a single identity. (prnewswire.com)
Since then, Ethos has continued building out its leadership bench and product pipeline. The company appointed Matt Amigh as CFO in late 2024, with Shearson describing him as an experienced operator, and has kept a visible presence at major trade events. At Global Pet Expo 2025, company messaging highlighted more than 100 new and reformulated products across Natural Balance and Canidae, suggesting Ethos is pursuing growth not just through merger integration, but through a fast product refresh cycle aimed at evolving consumer demand. Ethos executives have also emphasized science-backed nutrition, safety testing, transparency, and sustainability, with Natural Balance leaning on its Limited Ingredient Diet heritage and Canidae continuing to foreground regenerative agriculture and updated All Life Stages offerings. (petfoodprocessing.net)
Industry commentary around the broader pet food market helps explain why that message is resonating. NielsenIQ’s recap of Global Pet Expo 2025 pointed to a market still shaped by premiumization, humanization, innovation in formats and ingredients, and more price-sensitive shopping behavior under inflationary pressure. In that context, Ethos appears to be trying to hold two ideas at once: premium positioning and perceived value. That’s a familiar balancing act across pet nutrition, especially as pet parents look for targeted health benefits, cleaner labels, and stronger trust signals without giving up affordability altogether. (nielseniq.com)
Why it matters: For veterinary professionals, the Shearson interview is useful less as hard news than as a signal of where a growing pet food platform may be headed. Consolidation can give brands more resources for manufacturing, marketing, customer support, and product development, all of which can influence what pet parents ask about in exam rooms. Ethos has publicly highlighted safety testing, transparency, limited-ingredient positioning, and access to veterinary technician support, which are all features likely to appeal to pet parents managing food sensitivities, GI concerns, or ingredient scrutiny. At the same time, veterinary teams will want to keep distinguishing between strong consumer messaging and the level of clinical evidence behind specific diets, especially as “science-backed” claims become more common across the category. (prnewswire.com)
There’s also a channel implication. Ethos has said its brands are sold through pet specialty, independent, and ecommerce channels, not that it is building a veterinary-exclusive nutrition model. That means clinics are more likely to encounter these products through client questions than through direct dispensing. For practices, that raises a practical need: clear, evidence-based guidance on limited-ingredient diets, life-stage formulations, sustainability claims, and when over-the-counter premium foods are or aren’t appropriate substitutes for therapeutic nutrition. (prnewswire.com)
What to watch: The next signals will likely come from product launches, executive hires, retail distribution moves, and any deeper push into condition-specific nutrition or veterinary-facing education. If Ethos keeps pairing merger scale with rapid innovation, veterinary professionals should expect the company’s brands to stay visible in conversations with pet parents who are looking for premium, transparent, and purpose-positioned diets. (petfoodprocessing.net)